Oral administration of L-mR18L, a single domain cationic amphipathic helical peptide, inhibits lesion formation in ApoE null mice. (Q34287846)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Oral administration of L-mR18L, a single domain cationic amphipathic helical peptide, inhibits lesion formation in ApoE null mice. |
scientific article |
Statements
Oral administration of L-mR18L, a single domain cationic amphipathic helical peptide, inhibits lesion formation in ApoE null mice (English)
Shaila P Handattu
Geeta Datta
Richard M Epand
Raquel F Epand
Mayakonda N Palgunachari
Candyce E Monroe
Tamara D Keenum
Manjula Chaddha
G M Anantharamaiah
David W Garber
14 September 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference